Aurobindo Pharma has informed that a Meeting of the Board of Directors of the Company will be held on August 09, 2013, to consider the Un-Audited Financial Results of the Company for the quarter ended June 30, 2013 (Q1).
The above information is a part of company’s filings submitted to BSE.